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THE TERRIBLE IMBALANCE: HUMAN ORGANS
AND TISSUES FOR THERAPY-A
REVIEW OF DEMAND AND
SUPPLY
Russell Scott *
I. SHORTAGE AND ALLEVIATION
In June 1977, the Australian Law Reform Commission posed four "fun-
damental questions"' about the use of human tissues for transplantation, one
being: "Is there an adequate supply of tissue?"' The Commission's short
answer was that "there is not."3 Fifteen years later, the answer remains the
same, not only in Australia but worldwide. Today, the scarcity of organs
and tissues for transplantation is such that one commentator has character-
ized it as "the terrible imbalance between supply and demand,"4 and the
World Health Organization has found it necessary to take international ac-
tion aimed at curbing the rising commercial traffic in human body parts. 5 In
general, Western governments support and assist the quest for increased tis-
sue supply.
The Australian Law Reform Commission's "fundamental questions," and
its answers were published in its report Human Tissue Transplants (the
"ALRC Report").6 In this report, the Commission also covered such sub-
jects as the desirability of using human tissues for therapy, the possible
means of increasing tissue supply, the establishment of a national tissue reg-
* LL.B. (Honors) Sydney University. Solicitor of the Supreme Courts of New South
Wales and England; former Commissioner of the Australian and New South Wales Law Re-
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1. AUSTRALIAN LAW REFORM COMM'N, HUMAN TISSUE TRANSPLANTS 9 (1977)
[hereinafter "ALRC REPORT"]. The members of the Division of the Commission which pro-
duced the report included the Commission's chairman at the time, Mr. Justice Michael D.
Kirby. The writer was Commissioner-in-Charge of the Project.
2. Id. The ALRC's "fundamental questions" related also to the use of human tissues for
education, research, "and other medical therapy" as well as transplantation. Id. at 9-10.
3. Id. at 9.
4. William E. Braun, Every Kidney Counts, 327 NEw ENG. J. MED. 883, 883 (1992).
5. WORLD HEALTH ORG., HUMAN ORGAN TRANSPLANTATION-A REPORT ON DE-
VELOPMENTS UNDER THE AUSPICES OF WHO (1987-91) (1991) [hereinafter WHO REPORT].
6. ALRC REPORT, supra note 1.
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ister, and the underlying principles that should characterize the law and reg-
ulation of transplant technology.7 The report included a model draft of
legislation' that, with minor variations from state to state, was subsequently
enacted throughout Australia and remains in force today.
Since publication, the ALRC Report has been scrutinized frequently, par-
ticularly in Europe and the Americas, including recent examination by the
Canadian Law Reform Commission in its significant 1992 Working Paper
entitled Procurement and Transfer of Human Tissues and Organs (the
"CLRC Report"). 9 The CLRC Report is a substantial response to the
shortage of therapeutic tissues and the legal and ethical issues "provoked by
demand and supply disequilibria."' It is also timely because it exhibits a
comprehension that there are diverse reasons for the shortage as well as a
"necessarily limited role''" for the law in producing remedies.
Concerns about many aspects of the persistent worldwide scarcity are well
reflected in the current medical and bioethical literature, including The Jour-
nal of the American Medical Association, 2 The New England Journal of
Medicine,13 The Lancet,'4 The British Medical Journal,'5 The Medical Jour-
nal ofAustralia, 6 and The Hastings Center Report. 7 Government action in
the United States during the 1980s was considerable and included "a wave of
tissue transfer and procurement legislation"'" enacted in over forty-four
states, plus federal legislation that led to national computerization of organ
exchange data, a national task force to study organ procurement, and a ban
7. Id. at 10-13.
8. Id. at 135-36.
9. CANADIAN LAW REFORM COMM'N, PROCUREMENT AND TRANSFER OF HUMAN
TISSUES AND ORGANS, chs. 3, 4 & app. B (1992) [hereinafter CLRC REPORT].
10. Id. at 4.
11. Id. at 170.
12. Roger W. Evans et al., The Potential Supply of Organ Donors, 267 JAMA 239, 240
(1992); Antonia C. Novello, Increasing Organ Donation-A Report from the Surgeon General's
Workshop, 267 JAMA 213, 213 (1992).
13. Braun, supra note 4, at 885; Correspondence: The Shortage of Organs for Transplanta-
tion, 326 NEW ENG. J. MED. 1024, 1024-27 (1992).
14. Organ Donation in the UK, 340 LANCET 785, 785 (1992); Organ Transplantation,
340 LANCET 300, 300 (1992); Jean-Michael Bader, France. Transnational Transplants 340
LANCET 108, 108 (1992); Dilip S. Kittur et al., Incentives for Organ Donation?, 338 LANCET
1441, 1141 (1991).
15. Adrian D. Hibberd et al., Potential for Cadaveric Organ Retrieval in New South Wales,
304 BRIT. MED. J. 1339, 1339 (1992).
16. Jeremy R. Chapman, Transplantation in Australia-50 Years of Progress, MED. J.
AUSTL., July 6, 1992, at 46, 46; Tom E. Mandel, Organ and Tissue Transplantation 1992,
MED. J. AUSTL., July 6, 1992, at 3, 3.
17. James L. Nelson, Transplantation Through a Glass Darkly, HASTINGS CTR. REP.,
Sept.-Oct. 1992, at 6, 6.
18. CLRC REPORT, supra note 9, at 153.
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on commerce in human organs.' 9 Federal administrative action similar to
some of these initiatives has also been taken in Australia.2 °
In Europe, the Strasbourg-based Council of Europe, representing some
twenty-five nations, has played a harmonizing role in an effort to encourage
uniform European regulation. It commenced this effort with its model
codes of 197821 and 197922 and has continued in this endeavor with its re-
port on the Third Conference of European Health Ministers of November
198723 and with the regular publication of statistical information.
It would not be an exaggeration to say that tissue and organ supply has
become a preoccupation of the transplant community which, for present
purposes, includes interested patients, families, surgeons, physicians, other
health professionals, patient support groups, legislators, and ethicists. In the
United States, the preoccupation is no doubt a function of greater surgical
success not yet accompanied by greater supply, despite the government ac-
tions of the 1980s. One commentator has summarized the American situa-
tion as follows: "With advances in organ transplantation technology, fewer
restrictions on patient selection, and improved outcomes, an ever-increasing
number of persons are likely to become candidates for transplantation. De-
spite major initiatives to increase the supply, from 1986 through 1989, the
number of donors available annually remained virtually unchanged ....
It is becoming increasingly apparent that in the absence of authoritarian
measures, which in principle are not feasible in Western democracies, satis-
faction of the demand for organs and tissues will not be achieved by legisla-
tion alone, no matter how innovative; nor will it be achieved by a brisk,
linear, problem-solving approach on the part of lawmakers, task forces, or
public support groups, no matter how well-intentioned or compassionate.
Single solutions, such as the introduction of an "opting out" law, are un-
likely to achieve their purposes without a great deal more.
The more the causes of organ shortage are studied, the more difficult
19. Id. at 156.
20. The Australian Coordinating Committee on Organ Registries and Donation was cre-
ated by the Australian Health Ministers Advisory Council, North Sydney, New South Wales,
Australia.
21. Committee of Ministers, Council of Europe, Resolution (78) 29 On Harmonisation of
Legislations of Member States Relating to Removal, Grafting and Transplantation of Human
Substances (adopted May 11, 1978).
22. Committee of Ministers, Council of Europe, Recommendation No. R (79) 5 of the
Committee of Ministers to the Member States Concerning International Exchange and Trans-
portation of Human Substances (adopted Mar. 14, 1979).
23. Conference of Health Ministers, Council of Europe, Organ Transplantation: Third
Report, Legislative Measures in Relation to Organ Transplantation and to European Co-Opera-
tion (1987).
24. Evans, supra note 12, at 239 (footnotes omitted).
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seems the task of alleviation. One of the many reasons for this difficulty is
the paucity of empirical research and information on the reasons for the gap
between the numbers of actual and potential donors. One careful study pub-
lished in the United States in 1992 found that "[d]epending on the class of
donor considered, organ procurement efforts are between 37% and 59% effi-
cient. '' 25 The report concluded: "Realistically, it may be possible to increase
by 80% the number of donors available in the United States.... It is con-
ceivable, although unlikely, that the supply of donor organs could achieve a
level to meet demand.
' 26
Similarly, in the CLRC Report, the Canadian Law Reform Commission
said, "Only 10 to 20 per cent of potential organ donors currently become
actual donors. Yet the federal-provincial transplant taskforce has concluded
that a sufficient supply of organs is 'potentially available.' "27
The translation of tissue shortage into tissue adequacy is, according to
these authorities, a possibility in North America. Why, then, has it not been
achieved there or on any continent, given the efforts devoted to this end in
North America, Europe (numerous European nations have enacted "opting
out" legislation), and elsewhere? Indeed, information from the Swisstrans-
plant Foundation in the 1992 Council of Europe publication Transplant sug-
gests a continuous decline since 1987 in the total number of donors in
Switzerland, other European countries, and the United States: "[T]he total
number of donors available for organ transplantation [in Switzerland] has
regularly decreased since 1987. This phenomenon also observed in other
European countries, as well as in the United States becomes worrysome [sic]
for the future of transplantation.""
Whatever may be the reasons for the shortage, no real improvement is
likely to be produced by regulators, health professionals, or others without
intelligent exploration of the contours and terrain of the entire field of
human tissue transplantation, including:
(1) individual and community sensitivities about the procedures
that must be carried out on the body of a living person and on
a dead body in order to obtain body parts for transplant or
other therapy;
(2) the physical risks for a living donor;
(3) the risks and consequences of failure for a recipient;
(4) the significance of taking from living donors tissues or body
25. Id.
26. Id.
27. CLRC REPORT, supra note 9, at 35-36.
28. COUNCIL OF EUROPE, TRANSPLANT 49 (1992).
The Terrible Imbalance
parts that may be classified as single and vital, paired and vital,
regenerative, non-regenerative and reproductive;
(5) the social significance of taking tissue or a body part from a
living donor when:
(a) the donor has the capacity to give free and comprehending
consent;
(b) the donor lacks that capacity;
(c) the donor is related to the patient;
(d) the donor is not so related;
(e) the tissue is the subject of payment or commerce.
(6) the social significance of taking tissue or a body part from a
dead body (cadaver) when:
(a) the deceased while alive expressed a wish to donate tissue
after death;
(b) the deceased did not express any wish;
(c) in any such case the deceased's family is available and
agrees (or disagrees) with such taking.
Considering for a moment the classification of tissues as regenerative and
non-regenerative, significant differences between regenerative tissues them-
selves should be noted. For example, blood and bone marrow are live-sav-
ing, vital regenerative tissues, the supply of which is well organized and, in
the case of blood, usually adequate in Western communities. Livers are also
regenerative but, being vital organs, are of a different order. Other regenera-
tive tissues are non-vital, such as pieces of skin, hair, and waste body prod-
ucts. The characteristics and differences can be important in considering
attitudes to donation, reasons for shortage, and legal regulation. Living per-
sons are usually the source of such tissues.
A. Tissues from Living Donors
Procurement of tissues from living donors can raise issues concerning
human dignity, undue influence, family pressure upon a member to donate,
the morality of depleting a person's body, and the morality of removing tis-
sues from children or others who lack capacity or whose consent is not free.
Although sophisticated principles have been developed from the doctrine of
substituted consent, for the ostensible protection of minors and other incom-
petents (particularly in the United States), some people have difficulty in
accepting this concept under any circumstances.29 An extreme example that
caused global public debate was the action taken by a married couple in the
United Statess who conceived a baby for the purpose of providing bone mar-
row (which was taken in 1991 when the child was in her second year) to
29. RUSSELL ScoTr, THE BODY AS PROPERTY 111-14 (1981).
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another of their children who had fatal leukemia.3°
The debate over tissue donation by living persons for transplantation and
therapy has not been resolved internationally. For example, Australian
transplant legislation specifically allows live donation by adults, with sepa-
rate rules for regenerative and non-regenerative tissues. As for living mi-
nors, the Australian states have split, most effectively prohibiting donations
of non-regenerative tissues31 despite the Australian Law Reform Commis-
sion's model legislation (adopted in the Australian Capital Territory) that
would permit donation of non-regenerative tissue by mature minors in life-
and-death cases within a family, with supporting medical advice and the
supervision of an ad hoc government committee convened by a judge.32
Internationally, opinion has hardened in recent years against live dona-
tions, at least non-family live donations, as shown by the World Health Or-
ganization's 1991 report Human Organ Transplantation (the WHO
Report).33 The WHO Report presents a code of "Guiding Principles" on
human organ transplantation to all nations as the framework or model for
regulation or legislation. Guiding Principle Three begins: "Organs for trans-
plantation should be removed preferably from the bodies of deceased per-
sons. However, adult living persons may donate organs, but in general such
donors should be genetically related to the recipients."34
The WHO Report was the result of long-standing concerns of the World
Health Assembly about "trade for profit in human organs among living
human beings."3 In 1989, the Organization formed an international group
of advisors whose task was to prepare the code, giving special consideration
to this trade. The task was not easy, one reason being that notions of moral-
ity differ widely. Such familiar Western precepts as the necessity to facilitate
personal autonomy and to obtain personal consent for the removal of organs
(and for medical treatment) are neither accepted nor understood by some
societies, in which the individual "belongs" to the community, as the group
was reminded by an African delegate.
Nevertheless, the group identified two ethical principles as a desirable ba-
sis for all national regulation, the first being distributive justice and equity,
requiring that donated organs be made available to sick patients on the basis
of medical need and not on the basis of financial or comparable considera-
30. Lance Morrow, When One Body Can Save Another, TIME, June 17, 1991, at 54, 54.
31. See, e.g., Human Tissue Act, 1983, N.S.W. Inc. Acts No. 164, §§ 8, 10, 11 (1983)
(Austl.).
32. ALRC REPORT, supra note 1, at 124.
33. WHO REPORT, supra note 5.
34. Id.
35. Id. at 5.
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tions. The second was the principle of personal autonomy, seen by the group
as widely contravened in those parts of the world where commerce in human
body parts is, or has, flourished.36 There was no lack of evidence that living
vendors of human tissues in India and other parts of Asia tend to be the
poorest and weakest members of society, including those without capacity
and those in dependent relationships such as prisoners. Far from selling
their organs pursuant to genuine autonomous decisionmaking, these vendors
have been seen typically as responding to influences that negated autonomy
and contradicted the suggestion that their "consents" were free and
comprehending.
The WHO group considered arguments from transplant literature to the
effect that, in principle, official regulation or prohibition of a person's deci-
sion to sell his or her own body parts is paternalistic and an unacceptable
interference with autonomy, liberty, and freedom of contract.37 However,
evidence of the nature and consequences of some of the well-known com-
merce in organs that has taken place in India, Asia, and the United King-
dom led to a rejection of those arguments. Additionally, many nations in
the Americas, Europe, Africa, and the Pacific region have classified com-
merce in human organs and other tissues, either generally or on a selective
basis, as unacceptable, illegal, or criminal.38 Such initiatives, and WHO
Guiding Principle Three, are arguably evidence of growing aversion to organ
transfer between living non-related persons.
Disapproval of live organ donation also has been expressed on quite differ-
ent grounds. For example, the American transplant surgeon Thomas Starzl,
pioneer of liver transplants, has been reported as refusing to accept living
donors as early as 1972. On this point, Dr. Starzl has stated, "The most
compelling argument against living donation is that it is not completely safe
for the donor.
3 9
On the other hand, some see a place for live donation in transplantation
36. See G. M. Abouna et al., Commercialization in Human Organs: A Middle Eastern
Perspective, 22 TRANSPLANTATION PROCEEDINGS 918, 918 (1990) (detailing the Middle East-
ern practice of trading in human organs by using the poor and needy as victim donors); A. K.
Salahudeen et al., High Mortality Among Recipients of Bought Living- Unrelated Donor Kidneys
336 LANCET 725, 726-27 (1990) (describing Bombay's practice of "rampant commercialism"
in the buying and selling of organs through "kidney brokers" where the "whole enterprise is
predicated on profit for the transplanters and brokers").
37. CLRC REPORT, supra note 9, at 79-80.
38. See ALRC REPORT, supra note 1, at 135-36 (model legislation imposing criminal pen-
alties for such commerce). This model has been followed by all Australian states. Criminal
penalties also apply in the United States and the United Kingdom. In the Middle East, Ku-
wait has enacted a transplantation law providing for criminal penalties for the buying and
selling of organs. Abouna, supra note 36, at 920.
39. Morrow, supra note 30.
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and are not averse to encouraging its growth. The authors of a recent study
of organ procurement in the United States made the following closing
comments:
[I]f living-related and living-unrelated kidney donations were more
aggressively pursued, the demand for kidney transplantation could
conceivably be met .... Of the 9560 kidney transplantations per-
formed in 1990, 18.5% involved living donors. In 1982, 31.3% of
kidney transplantations involved living donors. Based on current
demand (ie, [sic] 18,592), it would clearly be undesirable if the ra-
tio of living to cadaveric donor transplantations decreased
further.' °
B. Cadaver Tissue Procurement
The 1992 Council of Europe publication Transplant provides a summary
of organ procurement for 1989, 1990, and 1991 in fifteen European countries
as well as the United Kingdom and the United States. It deals substantially
with cadaver donation and provides donor rates per million of population
(p.m.p.). In most countries, the donor rate was virtually static over the three
years, typical rates being between fifteen and twenty p.m.p.4" As noted ear-
lier, the Swisstransplant Foundation expressed concern over declining donor
rates in Switzerland and some other countries.42
Since the publication of Transplant, events in France have attracted atten-
tion. In July 1992, The Lancet carried a report on transplantation in France,
stating that because of its opting-out system, it was "not surprising that
France does more transplantations per million inhabitants than any other
European country."43 However, three months later, The British Medical
Journal reported a sudden massive decline in French organ procurement-a
thirty percent increase in refusals "in recent months."'
According to The British Medical Journal, the refusals followed "contro-
versy over the removal of organs from dead people without proper
authorisation and accusations that too many organs have been given to visit-
ing foreign patients."45 Despite the pioneering French Caillavet law which,
as early as 1976, decreed that the cadavers of all competent adult citizens
were to be available for organ removal, unless they had expressly objected or
40. Evans, supra note 12, at 245.
41. COUNCIL OF EUROPE, supra note 28.
42. See supra note 28 and accompanying text.
43. Bader, supra note 14, at 108.
44. Alexander Dorozynski, Organ Shortage Threatens French Transplant System, 305
BRIT. MED. J. 852, 852 (1992).
45. Id.
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opted out while alive (meaning obviously that specific authorization of re-
moval was not legally required),46 the French Health Minister, in the sum-
mer of 1992, issued an instruction that medical personnel should ask close
relatives whether dead potential donors had had any objection to donation. 7
The report stated that this procedural change followed a public complaint by
a couple that their dead son's eyes had been removed for transplantation
purposes "without authorisation."48 The Health Minister had also proposed
a reorganization of the French system of donation so that agreement or re-
fusal could be recorded by computer.49
The British Medical Journal report is puzzling because the French law of
1976 clearly states that cadaver organ retrieval is lawful except in two cir-
cumstances: the first being the case in which the dead person "made known"
an objection to removal while alive; the second being the case in which the
person was a minor or "of diminished mental capacity."5° As for cases in
which the deceased's objection is not formally recorded, the 1976 law con-
tains detailed rules for making inquiries of the deceased's family and close
relations to learn whether the deceased in fact objected to organ removal.
These inquiries are directed to ascertain whether the deceased objected, not
whether the family objects.
The case that apparently contributed to the sudden reduction in French
organ procurement involved removal of the complaining couple's "dead
son's eyes . . . without authorisation, "' but the report does not indicate
whether the deceased was a minor or an incompetent, which appear to be the
only circumstances (unless eyes are not to be regarded as organs) which
would necessitate "authorisation" by the family. As for the Health Minis-
ter's instruction that surviving family members must be asked whether dead
persons "had objections to donating"5 2 their eyes, the 1976 French law on
organ donation has always contained this requirement.5" Ignoring possible
complexities of legal interpretation, the fact appears to be that French organ
procurement suffered a major decline in 1992.
The administrative and legal contradictions implicit in these reports are
consistent with other findings of research and official inquiries in recent
years on the status of transplant laws, systems, and practices in various parts
46. Law No. 76-1181 (Concerning the Removal of Organs), art. 2 (Dec. 22, 1976) (Fr.).
47. Dorozynski, supra note 44, at 852.
48. Id.
49. Id.
50. Law No. 76-1181, art. 2 (Dec. 22, 1976) (Fr.).
51. Dorozynski, supra note 44, at 852.
52. Id.
53. See Law No. 76-1181, art. 2 (Dec. 22, 1976) (Fr.); see also ALRC REPORT, supra note
1, at 10 n.49 (describing the provisions of the French legislation).
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of the world. In the CLRC Report, the Canadian Law Reform Commission
examined the French procurement system under the rubric "Presumed Con-
sent-Opting Out" and found that "[i]n practice, French medical teams con-
tinue to solicit the consent of the families and deceased potential donors
' 54
despite the fact that, strictly, relatives have no legal right to refuse organ
removal based on their own objections."
After examining procurement practices in European nations, including a
number with opting-out legislation, the Council of Europe in 1988 stated
that "the practice in most countries shows that the relatives are consulted
and though in most cases its opinion is not legally overriding, none would go
against the expressed refusal of the family." 56 In Australia, a similar proce-
dure of seeking and acting only with family consent has evolved with gov-
ernment approval despite the fact that Australian legislation allows, in a
number of circumstances, a hospital to remove cadaver tissue without con-
sent either of the deceased or the family.
57
These practices suggest the possibility of ignorance or insensitivity on the
part of lawmakers, regulators, and expert advisers concerning adverse social
reaction to opting-out laws and preemptive legal powers that facilitate the
acquisition of human tissues for therapy when the source is the body of a
recently deceased person. Moreover, these practices suggest a failure to ex-
plore the contours of transplantation as suggested earlier.
Received wisdom for lawmaking and regulation has long been that a pri-
mary choice must be made between two opposed principles as the basis for
obtaining cadaver tissues for transplantation and other therapeutic pur-
poses."8 "Opting in" or "contracting in" requires an express consent by the
deceased or the surviving family for the removal of tissue, as seen in the
United Kingdom legislation. "Opting out," "contracting out," "routine pro-
curement," or "presumed consent" (as in France, Belgium, and Austria),
presumes the deceased to have consented to tissue removal in the absence of
express objection. Between the two extremes are "required request" and
"routine inquiry" (the United States) and "presumed consent following re-
quired inquiry" (Australia). All of these classifications of procurement sys-
tems are familiar in medical and bioethical literature and discourse and are
reflected in current national legislation. However, the reality of persistent
54. CLRC REPORT, supra note 9, at 149.
55. Id.
56. Id. at 153.
57. ALRC REPORT, supra note 1, at 127-28 (presenting draft of legislation entitled
"Transplantation and Anatomy Ordinance 1977").
58. Id. at 10-13; see also CLRC REPORT, supra note 9, at ch. 4.
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scarcity suggests that none of them generates enough tissues to satisfy
demand.
Altruism, "the unselfish concern for the welfare of others," 59 has re-
mained the moral foundation of a great deal of western transplant regula-
tion. The gift ethic (giving is better than taking) has underpinned much of
the thinking of ethicists and lawmakers since Titmuss's book on blood dona-
tion in 1970.60 So strongly entrenched are the words "donor" and "dona-
tion" in relation to the sources of transplant tissues that, despite the
semantic restriction to "gift" imposed by their Latin origins, they are typi-
cally used to describe respectively all persons from whom tissues are taken
whether dead or alive, and all tissues taken whether purchased or not. Fa-
miliar, if inconsistent, derivative expressions are "cadaver donor," "cadaver
donation," "live donor" (for a person who has sold his or her tissue), and
"rewarded donation" (or "rewarded gift"). There are currently signs of re-
newed scholarly examination of the relevance and effectiveness of altruism in
relation to tissue procurement.
As a principle to govern tissue procurement from the dead, altruism is to
be contrasted with "routine procurement" (removal without express gift).
Routine procurement and opting out (taking is better than giving) propose
that the saving of human life should be given priority over all emotional
attachment to the newly dead cadaver. It is at this chronological point that
formidable obstacles to the acquisition of tissues are likely to be encountered,
arising from deeply entrenched social values and beliefs. These obstacles
include atavistic moral, ethical, and religious rules about treatment of the
dead human body; concern for the dying and the newly dead; issues relating
to human dignity, privacy, autonomy, and the role of the family; difficulties
in accepting the fact that death occurs with cessation of brain function or
even the fact of death itself; and practices relating to burial, funerals, and
grieving. All may be encountered by those who seek to procure organs and
tissues from a brain-dead cadaver. It is not surprising that some health care
professionals deliberately avoid this whirlpool of human emotions despite
the life-saving potential of the organs and tissues that could be obtained.
The concept of brain death can be very difficult for some people to accept
in the presence of a dead body that has technologically induced blood circu-
lation, respiration, and the appearance of a sleeping, living person. Other
obstacles have been constructed by the news media that, from time to time,
have cast doubts on the certainty or accuracy of the brain death concept by
59. CLRC REPORT, supra note 9, at 39.
60. RICHARD M. TITMUSS, THE GIFT RELATIONSHIP: FROM HUMAN BLOOD TO SOCIAL
POLICY (1970).
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publicizing instances of so-called "recovery" by apparently dead patients
and, in one celebrated television program in the United Kingdom in 1980, by
suggesting that organ donors were not dead when organs were removed for
transplantation.6 This was followed, in succeeding months, by a cata-
strophic decline in organ donation in that country.62
Public confidence in the medical profession on this topic is essential. It is
important that intensive care experts and the medical profession speak with
one voice on the validity of the determination of death by reference to cessa-
tion of brain function and the criteria and procedures for its determination.
II. PERSISTENT TISSUE SHORTAGE: WHY?
There is ample evidence to support propositions that transplant technol-
ogy and surgical skills continually improve; that they have saved many
thousands of lives (and are often the only practicable treatment for dying
patients); and that there are enough organs and tissues potentially available
to satisfy demand. Nevertheless, organ shortage is ubiquitous and has per-
sisted since modern organ transplantation began, despite continuous expen-
diture of energy and resources by governments, health professionals, and
others aimed at increasing supply. These circumstances can suggest self-
contradiction and raise the question whether this apparent inconsistency
provides a feasible argument that society has been unable to come to grips
with the harsh realities of organ transplantation. Are we witnesses to two
streams of opinion that flow separately?
One stream may comprise the approval that comes from cured recipients
of transplanted tissues and their families, from medical experts and health
professionals who practice or support transplantation, and from community
satisfaction with the conquest of high-technology medicine over much sick-
ness and death. The other stream of opinion may contain negative concerns
about the cost of high-tech medicine and its effect on the provision of alter-
native means of health care, about the failure rates of organ transplants, and
about the possibility of loss of traditional human values and their replace-
ment with a "meat market" view of the newly dead human body through
which living human beings are seen as "pre-cadavers" or "bags of parts" for
the therapy of others. United States public opinion on organ donation is
consistent with this negative stream of opinion, and its measure was recently
summarized as follows: "Public opinion is a major consideration in organ
donation, and studies consistently have shown that people are not necessar-
61. Scorr, supra note 29, at 162-63.
62. Id. at 163.
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ily supportive of it."63
The diversity both of the tissues and of community attitudes to tissue do-
nation is illustrated by three recent papers. The first discusses animals (pri-
mates and other species) as a potentially substantial supply of transplantable
tissues for humans.' The second is a powerful, personal account of the rea-
sons for which two prominent experts in the sociology and ethics of organ
transplantation have decided to withdraw from further involvement in the
field.65 The third, which was precipitated by the murder of a prominent
Australian heart transplant surgeon, is an exploration of the relationship be-
tween the community and the technology of vital organ transplantation.66
A. Animals and Xenotransplantation
In opening his discussion of the first transplant of a baboon's liver to a
human,67 James L. Nelson draws attention to the divided community views
on xenotransplantation by referring to a protest demonstration against the
transplant at the University of Pittsburgh. 68 Nelson notes the advocacy by
transplant experts of the creation of colonies of primates whose organs could
be harvested as "a solution to the endemic lack of transplantable organs.
69
In fact, the baboon in question came from a federal government-approved
foundation in Texas where primates are bred specifically for use in re-
search.7" Referring to the moral issues, Nelson considers baboons on the
one hand, and on the other incapacitated humans who are permanently co-
matose, or those, such as anencephalic newborns, who are in "a condition
incompatible with either sensation or life."'" He argues that, at the very
least, human beings must answer the question, "What's so different about
the two kinds of creature?" 72 Nelson also argues that if we feel morally
constrained to continue organ transplantation for human therapy, we should
try to increase donation rates by improving our appeal to human altruism.73
63. Evans, supra note 12, at 244.
64. Nelson, supra note 17.
65. Renee C. Fox & Judith P. Swazey, Leaving the Field, HASTINGS CTR. REP., Sept.-Oct.
1992, at 9.
66. Lupton & Chapman, Death of a Heart Surgeon: Reflection on Press Accounts of the
Murder of Victor Chang, 303 BRIT. MED. J. 1583 (1991).
67. The transplant occurred in Pennsylvania in June 1992, to a thirty-five year-old father
of two whose liver had been destroyed by hepatitis. The patient died seventy-one days after the
surgery. Nelson, supra note 17, at 6.
68. Id.
69. Id. at 7.
70. Xenograft Recipient Dies, UNOS UPDATE 8:9, Sept. 1992, at 1.
71. Nelson, supra note 17, at 7.
72. Id.
73. Id. at 8.
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Professor Peter Singer of the Centre for Human Bioethics at Monash Uni-
versity, Australia, a well-known commentator on human attitudes to ani-
mals, bluntly describes the use of primates as organ donors as "speciesism
... logically parallel to racism and sexism."
74
Xenografts have been attempted since 1905, 7' and modern organ trans-
plantation has been characterized by the use of animal organs over a lengthy
period. The first heart transplanted to a human being-in 1964 at the Uni-
versity of Mississippi-belonged to an adult chimpanzee.76 Baboon and
chimpanzee hearts were transplanted by Dr. Christiaan Barnard in the
1970s, and animal-to-human kidney transplants took place in 1963 and 1964
in the United States with kidneys from chimpanzees, baboons, and
monkeys.77 Ox bone and pig and ape heart valves also have been success-
fully transplanted to humans.78 Despite this progress, reservations and ob-
jections about such transplants persist. They have been expressed by
members of the medical community, by those who believe on moral grounds
that animal organs should not be implanted in the human body regardless of
scientific justification, and, of course, by animal rights advocates.79
The future course of xenotransplantation is impossible to predict for at
least two reasons. The first is the acceptance in recent years of the entitle-
ment of animals to increased official protection and the widespread advocacy
for changes to animal status, particularly when the animal is the subject of
scientific and medical research.80 The second reason is the unknown future
response of the community in the event of increased implantation of animal
tissues in humans. Confusion may be augmented by a British plan to insert
human genes into fertilized pigs' ova so that the resulting transgenic pigs
may produce progeny with "human-ready" organs. 8
If baboons' hearts and pigs' vital organs were routinely used for placement
in the bodies of human beings, would we see a decline in the rate of human
tissue donation and a change in the perceptions of human beings concerning
themselves (and the animal species in question)? We should also consider
what effect xenotransplantation may have had already upon human organ
procurement and shortage.
74. Peter Singer, Xenotransplantation and Speciesism, 24 TRANSPLANTATION PROCEED-
INGS 728, 730 (1992).
75. Mark J. Hanson, A Pig in a Poke, HASTINGS CTR. REP., Nov.-Dec. 1992, at 2, 2.
76. SCOTT, supra note 29, at 39.
77. Id.
78. Id.
79. Id. at 40.
80. See, e.g., AUSTL. NAT'L HEALTH & MED. RESEARCH COUNCIL ET AL., AUSTRALIAN
CODE OF PRACTICE FOR THE CARE AND USE OF ANIMALS FOR SCIENTIFIC PURPOSES (1990).
81. Hanson, supra note 75, at 2.
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B. Rejecting Transplantation
In their article Leaving the Field,82 Renee C. Fox and Judith P. Swazey,
"the two sociologists most clearly identified with organ transplantation,,
8 3
discuss their reasons for departure from the field of transplantation after
some forty years and twenty-five years, respectively, of close involvement
and observation "coast to coast in this country (the United States) and [in]
Europe, Hawaii, Majuro and China." 4 They describe their experiences with
transplant teams, donors, recipients in operating rooms, other health profes-
sionals, patients, families, grave illnesses, frequent deaths, breakthroughs,
despair, and disappointments: "It is sometimes hard to meet the eyes of
patients who have improved enough ... to communicate their despair and
disappointment... [and who later say] 'no one ever told me it could be like
this.' "85
Identifying a recent American resistance to accepting "the limits to the
biological and human condition imposed by the aging process and our ulti-
mate mortality,,"6 Fox and Swazey agree with Paul Ramsey's observation
twenty years earlier that "[o]ur culture is already prepared for technocratiz-
ing the bodily life into collections of parts in which consciousness somehow
has residence for a time." ' They express the opinion that the "missionary-
like ardor about organ replacement that now exists"88 is out of hand, and
they deplore the current description of human tissues and organs by mem-
bers of the transplant community as "HBP's" (human body parts).8 9 This
leads them to suggest that the role of altruism and the Value of gift in trans-
plantation are being discounted deliberately in favor of a commodity or mar-
ket approach to human organs. Even though commerce in organs has been
outlawed by federal legislation in the United States, the authors believe that
the terminology "HBP's" has already led to a state of mind in some people
that has encouraged "the plundering of the newly deceased person's
body."9 By way of example, they refer to a 1991 organ donor from whose
body some fifty-six parts "went to people in different regions of the coun-
try. ' 91 Referring to the shortage of organs for transplant and the mounting
82. Fox & Swazey, supra note 65.
83. Id. at 9 (quoting editorial introduction).
84. Id.
85. Id. at 10.
86. Id. at 12.
87. Id. at 13 (quoting PAUL RAMSEY, THE PATIENT AS PERSON: EXPLORATIONS IN
MEDICAL ETHICS 193 (1970)).
88. Id. at 12.
89. Id. at 13.
90. Id. at 13-14.
91. Id. at 14.
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crisis in resource allocation in health care, the authors caution against excess
zeal in United States health expenditure on organ procurement while "mil-
lions of people do not have adequate or even minimally decent [health]
care."
92
Fox and Swazey conclude by describing their "leave taking" as a deliber-
ate separation "from what we believe has become an overly zealous medical
and societal commitment to the endless perpetuation of life and to repairing
and rebuilding people through organ replacement-and from the human suf-
fering, and . . . spiritual harm we believe such unexamined excess can, and
already has, brought in its wake."
9 3
Such a powerful caution could be seen as surprising in a society that has
had a persistent shortage of human tissues for therapy. On the other hand,
some may think that rising demand is a factor causing the shortage. Again,
it may be that, from experience, these experts have identified developments
in health care that result from changed attitudes to the human body, namely,
a lessening interest in the classical propositions of the body's inviolability
and inalienability, and a diminution in the overriding value of altruism. The
more efficient and successful "spare parts" surgery becomes, the less myste-
rious the body will seem. The remarkable rapidity of accumulation of
knowledge of the human genome through the current international genome
"mapping" project will accelerate this process.
C. Obsession with High Technology Medicine
In December 1992, The British Medical Journal published an article that
discussed "evidence of the exalted status of heart surgery in modern western
society."94 The article concerned public reaction to the murder of Austra-
lia's best-known heart transplant surgeon, Dr. Victor Chang, by gunmen
(later arrested and convicted) attempting extortion on a Sydney street. The
two authors, respectively from the Department of Community Medicine at
the University of Sydney and the Centre for Applied Social Research at
Macquarie University in New South Wales, examined the "massive news
coverage, far in excess of that accorded to any ordinary murder" generated
by this event. Lupton and Chapman argue that the reporting of Dr. Chang's
murder revealed a great deal about social attitudes towards "medical tech-
nology (especially transplantation and artificial organs), the body as
machine, and the heart as an elite and highly symbolic organ."95 The press
92. Id.
93. Id. at 15.
94. Lupton & Chapman, supra note 66, at 1584.
95. Id. at 1583.
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reports portrayed the murdered doctor "as a hero, saviour, saint, lifesaver,
able to bring people back to life from death."96 In a manner "reminiscent of
Biblical parables of the miracles performed by Christ,"97 they recounted Dr.
Chang's successful heart transplants to prominent people, young and old,
still alive who otherwise would have died long since.
Lupton and Chapman propose that two ideologies relate to modern heart
surgery, the first being public veneration of high technology itself and the
second involving the historic symbolism of the human heart as the seat of
the emotions. They suggest that heart transplant technology is seen by soci-
ety as an unprecedented demonstration of man's power over mortality.
Their approach is not without support. Indeed, it is not difficult to find re-
current reference in the literature of the Industrial Revolution to man's urge
to master nature, said by some to have been articulated first by Seventeenth
Century philosophers and scientists such as Bacon and Descartes, who en-
visaged a convergence of science and technology as the means by which that
mastery would be achieved.
The symbolic nature of the heart, according to the authors, has given it an
importance that sets it apart from other organs. The result is that its treat-
ment by heart surgeons as no more than a pump which, like a machine part,
can become defective and then be replaced with a new one, sets them apart
too, as "medical alchemists, offering the ultimate medical cure." 98
Lupton and Chapman propose that the media reaction and public mourn-
ing which followed Dr. Chang's death would have been unlikely if the mur-
der had been that of a prominent preventive health practitioner, a pioneer of
car-safety engineering, or an expert responsible for tobacco control legisla-
tion. They suggest that community values elevate high technology surgery
as a "cure" for heart disease above preventive medicine and public health
education of the kind that saw a dramatic decline in the United States deaths
from coronary heart disease between 1968 and 1976, fifty-four percent of
which was attributed "to lifestyle changes (principally reduction in smoking
and blood cholesterol levels) and only 3.5% to coronary artery bypass
surgery." 99
Whatever may be the comparative merits of heart transplantation and pre-
ventive medicine, there is no gainsaying the enormous public and news me-
dia response in Australia to the murder of Dr. Chang and its apparent
relationship to his reputation as a transplant surgeon. For different reasons,
96. Id. at 1584.
97. Id.
98. Id. at 1585.
99. Id.
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other transplant surgeons, including pioneers such as Dr. Thomas Starzl and
Dr. Norman Shumway of the United States and Sir Roy Calne of the United
Kingdom, also have been given great public prominence in recent decades in
many parts of the world."°
III. COMMENT
Many questions concerning tissue shortage and procurement spring to
mind, even if answers do not. If xenotransplants of vital organs could be
readily organized and eradicate disease and save human lives as well, why
should there not be strong public support for them arising from the same
attitudes that support human consumption of meat from animals and birds?
If the organs of dead human beings can eradicate disease and save human
lives, why is there not strong public support for their routine removal for
transplantation because everybody knows that they can never again be of use
to the deceased and will decay within a very short time? Again, if the pubic
truly admires high technology medicine and puts the transplant surgeon on a
pedestal, why is there not strong public support for therapeutic transplanta-
tion of routinely-removed transplantable body parts? Another question,
asked above, is whether society has been unable to come to grips with the
harsh reality of organ transplantation.
One response may be that such questions are simplistic and that there
already exists a great deal of public support for therapeutic tissue transplan-
tation. An example that is often overlooked is blood donation and transfu-
sion which are taken for granted and are so widely practiced that many have
forgotten that blood transfusion is the transplantation of a vital human
tissue.
It is possible that leaders of public discussion in this field-philosophers,
moralists, and lawmakers-have been too occupied with their own disci-
plines and with telling the community how to respond to transplantation
when they should have spent more time learning from the community? In-
stead of devising general legal formulae for the acquisition and use of all
human tissues, should we not first identify those tissues, the removal of
which gives the community no qualms-for example, regenerative material
such as blood, skin, and body products that can be safely taken from living
donors? Next, should we not separately deal with unusual regenerative tis-
sues such as bone marrow and that single, vital organ, the liver? (Part of a
living person's liver can be transplanted and will grow in the recipient's body
while the remainder will generate to normal size in the donor's body.)
100. See, e.g., Starz. Shumway and Caine Awarded Medawar Prize, UNOS UPDATE 8:9,
Sept. 1992, at 1.
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The growing official disapproval of body-part donation by living persons
does not relate to all tissues but to certain non-regenerative tissues, the re-
moval of which is not fatal, but is seen as mutilating or is otherwise unac-
ceptable (for example, kidneys and eyes). Donation by a living person of a
single, vital organ such as the heart, appears to be beyond discussion because
of the laws of murder and suicide. However, it is not difficult to envisage
circumstances in which a parent or child would be willing to give up his or
her life to save that of another family member. Such classifications of tissue
are relevant to living donors rather than cadavers because, with the dead
body, differences between regenerative and non-regenerative tissues, and
paired, single, vital, and non-vital organs are of less importance than social
attitudes about death, grieving, burial, and treatment of the corpse.
Obviously, the culture of a community will govern the amount of discus-
sion, education, consultation, and time that is needed for the public, and
bereaved families in particular, to tolerate willingly the removal of the or-
gans and tissues of the dead for the therapy of the sick. For example, a
Japanese author has recently confirmed that "[iun Japan neither the concept
of brain death nor the practice of organ transplantation are accepted."' °
The author supports this statement by reference to traditional Japanese be-
liefs that "personhood is a collective reality,"'0 2 not a concept that relates
solely to one individual. Traditionally, a newborn child is not seen as a per-
son, nor is the death of a person recognized, until completion of family and
community rituals."13 However, the author suggests that the modernization
of Japanese society since the 1960's has caused measurable change in accept-
ance of the therapeutic use of human tissues and even in the removal of
organs for transplantation from brain-dead cadavers.'°4
By way of contrast, at the time of an Informal Consultation called in 1990
in Geneva by the World Health Organization for the preparation of Guiding
Principles on organ transplantation, the Belgian Delegate,10 5 an eminent re-
nal physician, orally expressed the opinion that organ donation in Belgium
had greatly increased following the 1986 Belgian opting-out legislation. In
his opinion, the increase was assisted by a comprehensive program of public
information, education, and consultation underwritten by the Belgian Gov-
101. Jiro Nudeshima, Obstacles to Brain Death and Organ Transplantation in Japan, 338
LANCET 1063, 1063 (1991).
102. Id.
103. Id.
104. Id. at 1063-64.
105. The delegate was Professor P. Micheilsen of the Nephrology Department, U.Z. Gas-
thuisberg, Leuven, Belgium.
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ernment with the support of the health care professions and community
organizations.
IV. CONCLUSION
Generation of supplies of human organs and tissues for therapeutic use in
quantities that might satisfy demand will require a real understanding of the
sensitivities of the community in question; efficient organization; the best
expertise of a number of disciplines such as ethics, resource allocation, phi-
losophy, and social science; public education; innovative regulation or legis-
lation; and confidence and trust on the part of the community in its health
professions and lawmakers. There is as yet little evidence of a successful
result in any community despite continuous improvement in medical tech-
nology and support from national and provincial governments. Even so, it is
submitted that the benefits offered to the sick and the dying by the therapeu-
tic use of human tissues justify continuing efforts to increase supply and to
control abuses, particularly abuses associated with living persons, such as
traffic and commerce in human tissues and human beings. As suggested by
the Canadian Law Reform Commission, a common goal of law and public
policy should be the creation of "a safe and adequate, just and efficient, tis-
sue transfer and supply system."' °6
106. CLRC REPORT, supra note 9, at 193.
